. . . . . . . "[Importantly, LXR? activation displayed melanoma-suppressive cooperativity with the frontline regimens dacarbazine, B-Raf inhibition, and the anti-CTLA-4 antibody and robustly inhibited�melanomas that had acquired resistance to�B-Raf inhibition or dacarbazine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:04+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .